@article{11237,
  keywords = {Humans, United Kingdom/epidemiology, Female, Middle Aged, Aged, Male, Incidence, Adult, *Breast Neoplasms/epidemiology/mortality, Prevalence, Aged, 80 and over, Adolescent, Young Adult, Breast Neoplasms, Male/epidemiology/mortality, Survival Rate},
  author = {N. Barclay and E. Burn and A. Delmestri and T. Duarte-Salles and A. Golozar and W . Y. Man and E. Tan and I. Tietzova and D. Prieto-Alhambra and D. Newby},
  title = {Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021},
  year = {2024},
  journal = {Sci Rep},
  volume = {14},
  edition = {2024/08/18},
  number = {1},
  pages = {19069},
  isbn = {2045-2322},
  doi = {10.1038/s41598-024-69006-1},
  note = {2045-2322
Barclay, Nicola L
Burn, Edward
Delmestri, Antonella
Duarte-Salles, Talita
Golozar, Asieh
Man, Wai Yi
Tan, Eng Hooi
Tietzova, Ilona
OPTIMA Consortium
Prieto-Alhambra, Daniel
Newby, Danielle
806968/Innovative Medicines Initiative 2 (IMI2) Joint Undertaking/
101034347/optima/
Journal Article
England
Sci Rep. 2024 Aug 17;14(1):19069. doi: 10.1038/s41598-024-69006-1.},
  language = {eng},
}